Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

Abstract Background High-risk human papillomavirus (HR HPV) testing is already part of cervical cancer screening programs in a number of countries. New tests need to be validated not only in clinical studies but also in routine screening settings with regard to their clinical performance. Methods Th...

Full description

Bibliographic Details
Main Authors: Thomas Iftner, Lisa Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke-Jarboui, Nathalie Iftner, Reinhard von Wasielewski, Peter Martus, Gerd Boehmer
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Abbott RealTime High Risk HPV
Hybrid Capture
HPV
Cervical cancer screening
Online Access:http://link.springer.com/article/10.1186/s12879-016-1994-0

Internet

http://link.springer.com/article/10.1186/s12879-016-1994-0

Similar Items